Charles River offers discovery research services and studies replicating a wide range of neurological and psychiatric diseases in various rodent species to support the pharmaceutical, biotech and academic sectors in their Central Nervous System (CNS) drug development and medical testing programs.

These services and studies are conducted in our proprietary laboratories by highly experienced scientific and technical staff who are committed to delivering high-quality, decision-making data for your CNS drug discovery projects.